Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the european study: Molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

1. Haberichter, S.L.
2. Castaman, G.
3. Budde, U.
4. Peake, I.
5. Goodeve, A.
6. Rodeghiero, F.
7. Federici, A.B.
8. Batlle, J.
9. Meyer, D.
10. Mazurier, C.
11. Goudemand, J.
12. Eikenboom, J.
13. Schneppenheim, R.
14. Ingerslev, J.
15. Vorlova, Z.
16. Habart, D.
17. Holmberg, L.
18. Lethagen, S.
19. Pasi, J.
20. Hill, F.G.H.
21. Montgomery, R.R.